Association between perception of care coordination and health outcomes in Korean cancer survivors

Shin, Jinyoung; Shin, Dong Wook; Lee, Jungkwon; Hwang, Ji Hye; Yoo, Jung Eun; Ko, Hyeonyoung; Song, Yun-Mi

doi:10.1186/s12955-020-1279-6

Health and Quality of Life Outcomes

Table 3 Clinical and psychosocial outcomes and quality of life according to the level of care coordination

From: Association between perception of care coordination and health outcomes in Korean cancer survivors

Measurement tools	(range)	Overall (N = 1306)	Uncoordinated group (N = 167)	Intermediate group (N = 494)	Coordinated group (N = 645)	P-for trend*
Measurement tools	(range)	N (%) Mean ± SD	N (%) Mean ± SD	N (%) Mean ± SD	N (%) Mean ± SD	P-for trend*
New comorbidity after cancer diagnosis		396 (30.3)	55 (32.9)	159 (32.2)	182 (28.2)	0.039
Type of new Comorbidity						< 0.001
Cerebrovascular		16 (1.2)	3 (1.8)	8 (1.6)	5 (0.8)
Hypertension		65 (5.0)	10 (6.0)	26 (5.3)	29 (4.5)
Diabetes mellitus		23 (1.8)	1 (0.6)	9 (1.8)	13 (2.0)
Dyslipidemia		105 (8.0)	15 (9.0)	39 (7.9)	51 (7.9)
Mental disorder		14 (1.1)	2 (1.2)	4 (0.8)	8 (1.2)
Others^a		173 (13.2)	24 (14.4)	73 (14.8)	76 (11.8)
No of new comorbidity	0–4	0.42 ± 0.72	0.44 ± 0.75	0.48 ± 0.79	0.37 ± 0.66	0.012
No of clinic visiting, yearly	1–14	2.4 ± 1.6	2.8 ± 1.9	2.5 ± 1.5	2.3 ± 1.6	0.004
EQ_VAS^b	0–100	68.1 ± 16.7	64.6 ± 18.1	67.1 ± 17.3	69.8 ± 15.7	< 0.001
EORTC QLQ-C30
Global health status/QOL	0–100	66.4 ± 18.7	63.7 ± 20.0	64.8 ± 19.0	68.4 ± 17.9	0.001
Functional scales^b
Physical functioning	0–100	81.1 ± 16.2	77.4 ± 15.7	80.1 ± 16.4	82.8 ± 16.0	< 0.001
Role functioning	0–100	86.4 ± 20.1	81.0 ± 22.5	83.5 ± 22.0	90.0 ± 17.0	< 0.001
Emotional functioning	0–100	80.0 ± 20.2	73.1 ± 22.5	76.1 ± 21.1	84.8 ± 17.6	< 0.001
Cognitive functioning	0–100	75.6 ± 19.3	71.4 ± 19.2	74.8 ± 19.7	77.3 ± 18.9	0.001
Social functioning	0–100	80.0 ± 23.2	77.3 ± 25.6	76.8 ± 23.7	83.1 ± 21.7	< 0.001
Symptom scales^c
Fatigue	0–100	33.8 ± 24.6	43.1 ± 24.1	37.4 ± 25.9	28.7 ± 22.4	< 0.001
Nausea and vomiting	0–100	10.3 ± 16.3	14.4 ± 19.9	11.7 ± 17.2	8.1 ± 14.2	< 0.001
Pain	0–100	17.8 ± 22.0	21.6 ± 22.9	21.4 ± 24.1	14.1 ± 19.2	< 0.001
Dyspnea	0–100	16.7 ± 22.3	23.6 ± 24.9	19.6 ± 22.4	12.7 ± 20.7	< 0.001
Insomnia	0–100	29.5 ± 32.1	38.5 ± 31.9	30.2 ± 31.3	26.6 ± 32.3	< 0.001
Appetite loss	0–100	13.9 ± 24.0	20.8 ± 24.4	14.9 ± 27.5	11.4 ± 20.3	< 0.001
Constipation	0–100	18.6 ± 25.1	25.0 ± 26.8	21.7 ± 26.3	14.6 ± 23.1	< 0.001
Diarrhea	0–100	21.7 ± 25.3	26.1 ± 29.1	23.5 ± 25.5	19.2 ± 23.8	< 0.001
Financial difficulties	0–100	18.4 ± 26.9	20.6 ± 29.9	19.7 ± 27.0	16.9 ± 25.9	0.086
K-FCRI
Triggers^c	0–32	13.1 ± 6.8	15.1 ± 7.3	13.6 ± 7.0	12.0 ± 6.3	< 0.001
Severity^c	0–36	11.2 ± 7.3	13.6 ± 7.4	12.4 ± 7.2	9.6 ± 6.9	< 0.001
Psychological distress^c	0–16	4.2 ± 3.9	5.3 ± 3.9	4.6 ± 4.1	3.5 ± 3.6	< 0.001
Functional impairment^c	0–24	5.0 ± 5.4	5.2 ± 5.2	5.1 ± 5.7	4.9 ± 5.3	0.920
Coping strategies^b	0–36	19.1 ± 7.6	18.3 ± 8.2	18.6 ± 7.1	19.9 ± 7.6	0.005
Insight^c	0–12	1.3 ± 2.1	1.8 ± 2.7	1.6 ± 2.2	1.0 ± 1.8	0.014
Reassurance^b	0–12	5.0 ± 3.2	4.7 ± 2.9	4.9 ± 3.2	5.1 ± 3.4	0.129

Data were presented as mean value ± standard deviation, number, or number (percentage)
EQ-VAS EuroQoL Visual Analogue Scale, EORTC QLQ-C30 The European Organization for Research and Treatment of Cancer 30-item quality of life questionnaire, QOL quality of life, K-FCRI Korean version of fear of cancer recurrence index. *P values for trend were obtained by linear regression analysis after adjusting for age, sex, cancer site, marital status, cancer stage, treatment modality, type of care providers and duration since cancer diagnosis. ^aOthers included thyroid disease, liver disease, lung disease, osteoporosis, lymphedema, peripheral neuropathy, and anemia. ^bHigher score means better health status. ^cLower score means better health status

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com